Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders. - Wikidata - wikimedia - TriplyDB

Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.

Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.

http://www.wikidata.org/entity/Q31149409

about

Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis.Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of Myelofibrosis.Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.Human gastric epithelium produces IL-4 and IL-4delta2 isoform only upon Helicobacter pylori infection.Myelofibrosis: molecular and cell biological aspects.

P2860

Q26777398-E4F4D6FB-9846-4044-A932-C6CE3C7692AE Q35607194-6AD3A1F9-C113-4F36-98F7-F9313CCAA95F Q36012537-A688CB3E-88AB-42C3-98E5-65E7EEC49581 Q36263805-2E64BD0B-E61D-42A2-B075-4A2E125EB907 Q36512309-8ABFC5B1-E37F-4E15-80F4-F409DCF6C60A Q40027763-624A9A26-C4B6-484F-BF9C-C3C9A702D051 Q41952793-BFE5A9DD-BA23-4AD4-A83B-4E7124A91A2E

P2860

Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.

http://www.wikidata.org/entity/Q31149409

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Aberrant expression of transfo ...... myeloproliferative disorders.

@ast

Aberrant expression of transfo ...... myeloproliferative disorders.

@en

type

label

Aberrant expression of transfo ...... myeloproliferative disorders.

@ast

Aberrant expression of transfo ...... myeloproliferative disorders.

@en

prefLabel

Aberrant expression of transfo ...... myeloproliferative disorders.

@ast

Aberrant expression of transfo ...... myeloproliferative disorders.

@en

P1433

Q31149409-E76A5C74-ACB3-4DCC-B87B-9544508202B7

P1476

Q31149409-A99CA217-1592-45A5-851D-7727A9E0960B

P2093

Q31149409-33C125EA-7E8F-4EEC-B1A5-CA7584A19894

Q31149409-5F351180-81C0-496B-9C95-C35CFFF53C71

Q31149409-6FDCECB4-5417-413E-83E0-E316C42435C1

Q31149409-A5495E0D-316E-4769-BB82-65F18334C3EA

Q31149409-BC1E9B5F-CDE4-42E7-84F9-3E74731091B9

Q31149409-D28FD33B-6783-4E59-8972-20FE6B9E00AD

P2860

Q31149409-0CD211CC-141C-44B3-94A5-69A6AF24040E

Q31149409-17EAD423-978F-48FC-9449-7137ED31A522

Q31149409-3F37DB41-E1D9-4807-929F-FA8893B5FF29

Q31149409-4A6853C3-BB6C-4E14-A5BA-F92B49711137

Q31149409-50F6D0F8-FF9B-4340-8CCD-9DB2E30ABE80

Q31149409-67E9AA1E-8C8B-4E75-8AFE-CFD4D6872688

Q31149409-6B84797E-3D3F-42B5-B2C0-C4814AFBC35A

Q31149409-8F1FF48B-DC2B-40CD-9E46-9822B30BC7F1

Q31149409-AD3C6CCC-13B3-45DC-9D38-029F68EA1613

Q31149409-AF142BAF-9B30-4D9E-85CD-85D9D8812711

P304

Q31149409-A9536A5E-F6AB-4E3C-B31B-A225BBF1D977

P31

Q31149409-A2E0E0F7-D1FD-41E8-9868-0084CC5A4609

P356

Q31149409-AE8D5869-B19C-439E-9811-269CC4C54F1C

P433

Q31149409-0B4CC608-BFC0-410E-896E-022454297352

P478

Q31149409-C218758C-1C48-4F13-AA71-F580CFE9291D

P577

Q31149409-3FB99585-4B93-4407-BA70-9456C980EC41

P698

Q31149409-AE9ADA24-6A5B-4DB7-B741-892CC6DA3183

P356

P1433

The Journal of Pathology

P1476

Aberrant expression of transfo ...... myeloproliferative disorders.

@en

P2093

Gero Loch

http://www.w3.org/2001/XMLSchema#string

Hans Kreipe

http://www.w3.org/2001/XMLSchema#string

Jerome Schlué

http://www.w3.org/2001/XMLSchema#string

Oliver Bock

http://www.w3.org/2001/XMLSchema#string

Reinhard von Wasielewski

http://www.w3.org/2001/XMLSchema#string

Ulrika Schade

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

TGF-beta signaling: positive and negative effects on tumorigenesis.

Identification of expressed genes by laser-mediated manipulation of single cells.

Thrombopoietin receptor (Mpl) expression by megakaryocytes in myeloproliferative disorders.

Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis.

Chronic myeloid disorders: Classification and treatment overview.

Transforming growth factor-beta signaling in normal and malignant hematopoiesis.

One-step extraction of RNA from archival biopsies.

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.

P304

548-557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.1744

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

205

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15726648

http://www.w3.org/2001/XMLSchema#string